Jain Shikha, Raval Devang A, Mitra Aarohi, Chaudhary Diksha, Khare Utkarsh
Department of Community Medicine, B.J. Medical College, Ahmedabad, Gujarat, India.
Indian J Community Med. 2022 Jan-Mar;47(1):138-141. doi: 10.4103/ijcm.ijcm_940_21. Epub 2022 Mar 16.
Ahmedabad city reported the highest number of cases and deaths. In order to guide various interventions and monitor future trends, evidence is required. Hence, we conducted the present study to explore the epidemiological determinants, clinical profile, risk factors, and predictors of mortality of COVID-19.
This was a retrospective record-based descriptive study of 2268 confirmed COVID-19 patients admitted in a designated COVID hospital of Ahmedabad city from March to July 2020.
The median age of patients was 54 years, and 60.9% of them were males. Majority (83.27%) had comorbidities; the most common comorbidity was hypertension (62.59%) followed by diabetes (44.76%). The most common symptoms reported were fever (69.76%), breathlessness (55.47%), and cough (53.18%). Majority (61.12%) of the patients showed lymphocytopenia, and in one-third (34.85%), D-dimer levels were elevated (>1 μg/ml). Odds of inhospital deaths were higher in patients having breathlessness and gastrointestinal symptoms and comorbidities. More of the deceased had leukocytosis and lymphocytopenia, high D-dimer levels, C-reactive protein, and altered liver function tests as compared to the survivors.
While making decisions such as prevention of exposure of high-risk population to the infection, control of the existing comorbid condition, and prioritization of this population for vaccination, criteria of case definition for surveillance keeping in mind the typical and atypical manifestations of the disease, require robust evidence which the current study could provide insight to.
艾哈迈达巴德市报告的病例数和死亡数最多。为指导各项干预措施并监测未来趋势,需要相关证据。因此,我们开展了本研究,以探索新冠肺炎的流行病学决定因素、临床特征、危险因素及死亡预测因素。
这是一项基于回顾性记录的描述性研究,研究对象为2020年3月至7月在艾哈迈达巴德市一家指定新冠肺炎医院收治的2268例确诊新冠肺炎患者。
患者的中位年龄为54岁,其中60.9%为男性。大多数(83.27%)患者有合并症;最常见的合并症是高血压(62.59%),其次是糖尿病(44.76%)。报告的最常见症状为发热(69.76%)、呼吸困难(55.47%)和咳嗽(53.18%)。大多数(61.12%)患者出现淋巴细胞减少,三分之一(34.85%)患者的D-二聚体水平升高(>1μg/ml)。有呼吸困难、胃肠道症状和合并症患者的院内死亡几率更高。与幸存者相比,死亡患者的白细胞增多、淋巴细胞减少、D-二聚体水平高、C反应蛋白及肝功能检查异常更为常见。
在做出诸如预防高危人群感染、控制现有合并症以及将该人群列为疫苗接种优先对象等决策时,考虑到该疾病的典型和非典型表现的监测病例定义标准,需要有力的证据,而本研究能够为此提供见解。